tradingkey.logo

DSS Inc

DSS
0.919USD
+0.037+4.20%
Fechamento 02/06, 16:00ETCotações atrasadas em 15 min
8.35MValor de mercado
PerdaP/L TTM

Mais detalhes de DSS Inc Empresa

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

Informações de DSS Inc

Código da empresaDSS
Nome da EmpresaDSS Inc
Data de listagemOct 27, 1993
CEOGrady (Jason)
Número de funcionários100
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 27
Endereço275 Wiregrass Pkwy
CidadeWEST HENRIETTA
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal14586
Telefone15852321500
Sitehttps://www.dssworld.com/
Código da empresaDSS
Data de listagemOct 27, 1993
CEOGrady (Jason)

Executivos da empresa DSS Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Packaging Printing and Fabrication
484.10K
7.57%
Commercial and Security Printing
78.00K
1.22%
Real Property Rental Income
16.00K
0.25%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Packaging Printing and Fabrication
484.10K
7.57%
Commercial and Security Printing
78.00K
1.22%
Real Property Rental Income
16.00K
0.25%

Distribuição de ações

Atualizado em: sáb, 31 de jan
Atualizado em: sáb, 31 de jan
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Alset Ehome International Inc
36.04%
Chan (Heng Fai Ambrose)
20.31%
Global Biomedical Pte Ltd.
3.08%
The Vanguard Group, Inc.
0.64%
Renaissance Technologies LLC
0.31%
Outro
39.63%
Investidores
Investidores
Proporção
Alset Ehome International Inc
36.04%
Chan (Heng Fai Ambrose)
20.31%
Global Biomedical Pte Ltd.
3.08%
The Vanguard Group, Inc.
0.64%
Renaissance Technologies LLC
0.31%
Outro
39.63%
Tipos de investidores
Investidores
Proporção
Corporation
39.11%
Individual Investor
20.31%
Investment Advisor
0.85%
Hedge Fund
0.34%
Investment Advisor/Hedge Fund
0.23%
Research Firm
0.03%
Outro
39.13%

Participação acionária institucional

Atualizado em: seg, 8 de dez
Atualizado em: seg, 8 de dez
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
35
145.92K
2.15%
--
2025Q3
36
145.92K
2.15%
-17.92K
2025Q2
35
163.84K
2.17%
-884.00
2025Q1
35
164.73K
1.72%
+7.88K
2024Q4
38
121.90K
3.03%
-50.52K
2024Q3
42
172.42K
3.04%
-10.61K
2024Q2
46
183.03K
2.83%
+19.66K
2024Q1
49
163.37K
2.83%
-36.31K
2023Q4
48
186.92K
3.41%
+16.51K
2023Q3
52
170.94K
7.14%
-2.49K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Alset Ehome International Inc
3.65M
40.14%
-581.39K
-13.74%
Oct 06, 2025
Chan (Heng Fai Ambrose)
2.06M
22.62%
--
--
Oct 06, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Oct 06, 2025
The Vanguard Group, Inc.
64.83K
0.71%
+43.10K
+198.36%
Sep 30, 2025
Renaissance Technologies LLC
31.45K
0.35%
+4.00K
+14.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
22.84K
0.25%
+3.65K
+18.99%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Sep 30, 2025
Citi Investment Research (US)
2.94K
0.03%
+2.94K
--
Sep 30, 2025
Tower Research Capital LLC
2.54K
0.03%
-1.89K
-42.63%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proporção0%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
Data
Data ex-dividendo
Tipo
Proporção
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
KeyAI